Thought Leadership

Thought Leadership, Rare diseases

Navigating the transition from open label extensions to early access programs

Thought Leadership, Insights & Propositions

Beyond adherence driving future healthcare through patient support programmes

Thought Leadership, Rare diseases

Leveraging Early Access Programs and Real-World Data for commercial success

Thought Leadership, Rare diseases

Launching successful patient support programs for rare disease patients across Europe

Thought Leadership, Rare diseases

Sciensus webinar with Fierce Biotech: Unlocking the European orphan drug market

Thought Leadership, Rare diseases

Market access for orphan drugs in Switzerland: a guide for Biotechs

Thought Leadership, Cancer

The benefits of digitally collecting PROMs to study patient wellbeing.

Thought Leadership, Rare diseases

The impact of real-world data in gaining access to the European orphan drugs market. 

Thought Leadership, Long-term conditions

White Paper: Quality of Life